Header

UZH-Logo

Maintenance Infos

Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy


Brendel, C; Hänseler, Walther; Wohlgensinger, Vital; Bianchi, Matteo; Tokmak, Serap; Reichenbach, J; Seger, R; Siler, Ulrich (2013). Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy. Human Gene Therapy. Methods, 24(3):151-159.

Statistics

Citations

Dimensions.ai Metrics
11 citations in Web of Science®
11 citations in Scopus®
12 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

136 downloads since deposited on 16 Jan 2014
25 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Division of Surgical Research
04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Genetics(clinical), Molecular Medicine, Applied Microbiology and Biotechnology, Genetics, Pharmacology
Language:English
Date:June 2013
Deposited On:16 Jan 2014 13:56
Last Modified:18 Aug 2018 13:41
Publisher:Mary Ann Liebert, Inc. Publishers
ISSN:1946-6536
Additional Information:This is a copy of an article published in Human Gene Therapy. Methods © 2013 Mary Ann Liebert, Inc.; Human Gene Therapy is available online at: http://www.liebertonline.com.
OA Status:Green
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1089/hgtb.2012.157
PubMed ID:23489116

Download

Download PDF  'Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy'.
Preview
Content: Published Version
Filetype: PDF
Size: 477kB
View at publisher